{"name": "Catalyst Biosciences",
 "permalink": "catalyst-biosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/catalyst-biosciences",
 "homepage_url": "http://www.catalystbiosciences.com/",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": 50,
 "founded_year": 2003,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "drug, proteases, hemostasis, inflammation",
 "alias_list": "",
 "email_address": "info@catbio.com",
 "phone_number": "(650) 871-0761",
 "description": "Healthcare Biotechnology",
 "created_at": "Tue Jun 23 18:50:53 UTC 2009",
 "updated_at": "Thu Dec 09 07:19:21 UTC 2010",
 "overview": "\u003Cp\u003ECatalyst Biosciences is a drug discovery and development company that is creating novel catalytic biopharmaceutical products based on engineered human proteases. The mission is to establish protease therapeutics as a new therapeutic platform comparable in depth and scope to antibody pharmaceuticals. The Company is developing proteases for the treatment of a broad range of diseases with a strong focus on hemostasis and inflammation. \u003C/p\u003E\n\n\u003Cp\u003EThe Company\u00e2\u20ac\u2122s product discovery platform is based on methods to rapidly create and characterize tailor-made protease drug candidates, called Alterase\u00e2\u201e\u00a2 therapeutics, that cleave disease-causing proteins or improve the biochemical and pharmacological properties of marketed protease drugs. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       95],
      "assets/images/resized/0005/0378/50378v1-max-150x150.png"],
     [[173,
       110],
      "assets/images/resized/0005/0378/50378v1-max-250x250.png"],
     [[173,
       110],
      "assets/images/resized/0005/0378/50378v1-max-450x450.png"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO ",
    "person":
     {"first_name": "Nassim",
      "last_name": "Usman",
      "permalink": "nassim-usman",
      "image": null}},
   {"is_past": false,
    "title": "Chief Financial Officer",
    "person":
     {"first_name": "William",
      "last_name": "Dawson",
      "permalink": "william-dawson",
      "image": null}},
   {"is_past": false,
    "title": "Board Director",
    "person":
     {"first_name": "G.",
      "last_name": "Steven Burrill",
      "permalink": "g-steven-burrill",
      "image":
       {"available_sizes":
         [[[99,
            150],
           "assets/images/resized/0027/2079/272079v1-max-150x150.jpg"],
          [[166,
            250],
           "assets/images/resized/0027/2079/272079v1-max-250x250.jpg"],
          [[183,
            275],
           "assets/images/resized/0027/2079/272079v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$70M",
 "funding_rounds":
  [{"round_code": "c",
    "source_url": "http://www.fiercebiotech.com/press-releases/catalyst-biosciences-raises-40-million-series-c-financing?utm_medium=nl\u0026utm_source=internal\u0026cmp-id=EMC-NL-FB\u0026dest=FB",
    "source_description": "Catalyst Biosciences Raises $40 Million in Series C Financing",
    "raised_amount": 40000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2008,
    "funded_month": 12,
    "funded_day": 3,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Johnson \u0026 Johnson Development Corporation",
         "permalink": "johnson-johnson-development-corporation",
         "image":
          {"available_sizes":
            [[[150,
               57],
              "assets/images/resized/0005/8402/58402v1-max-150x150.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-250x250.png"],
             [[225,
               86],
              "assets/images/resized/0005/8402/58402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Essex Woodlands Health Ventures",
         "permalink": "essex-woodlands-health-ventures",
         "image":
          {"available_sizes":
            [[[150,
               83],
              "assets/images/resized/0005/2525/52525v3-max-150x150.jpg"],
             [[250,
               139],
              "assets/images/resized/0005/2525/52525v3-max-250x250.jpg"],
             [[268,
               150],
              "assets/images/resized/0005/2525/52525v3-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Funds",
         "permalink": "novartis-ventures",
         "image":
          {"available_sizes":
            [[[150,
               14],
              "assets/images/resized/0004/4137/44137v1-max-150x150.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-250x250.png"],
             [[215,
               21],
              "assets/images/resized/0004/4137/44137v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Burrill \u0026 Company",
         "permalink": "burrill-co",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0402/50402v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-250x250.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "b",
    "source_url": "http://www.catalystbiosciences.com/news-pr-seriesb.html",
    "source_description": "CATALYST BIOSCIENCES RAISES $30 MILLION SERIES B FINANCING TO ADVANCE THERAPEUTIC PROTEASES",
    "raised_amount": 30000000.0,
    "raised_currency_code": "USD",
    "funded_year": 2006,
    "funded_month": 2,
    "funded_day": 9,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Morgenthaler Ventures",
         "permalink": "morgenthaler-ventures",
         "image":
          {"available_sizes":
            [[[150,
               73],
              "assets/images/resized/0001/2347/12347v1-max-150x150.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-250x250.png"],
             [[221,
               108],
              "assets/images/resized/0001/2347/12347v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "HealthCare Ventures",
         "permalink": "healthcare-ventures",
         "image":
          {"available_sizes":
            [[[150,
               20],
              "assets/images/resized/0004/9268/49268v1-max-150x150.jpg"],
             [[250,
               34],
              "assets/images/resized/0004/9268/49268v1-max-250x250.jpg"],
             [[290,
               40],
              "assets/images/resized/0004/9268/49268v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Sofinnova Ventures",
         "permalink": "sofinnova-ventures",
         "image":
          {"available_sizes":
            [[[150,
               26],
              "assets/images/resized/0003/0428/30428v1-max-150x150.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-250x250.jpg"],
             [[194,
               34],
              "assets/images/resized/0003/0428/30428v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Burrill \u0026 Company",
         "permalink": "burrill-co",
         "image":
          {"available_sizes":
            [[[150,
               25],
              "assets/images/resized/0005/0402/50402v1-max-150x150.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-250x250.png"],
             [[250,
               43],
              "assets/images/resized/0005/0402/50402v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "RCT BioVentures",
         "permalink": "rct-bioventures",
         "image":
          {"available_sizes":
            [[[81,
               60],
              "assets/images/resized/0026/6126/266126v1-max-150x150.png"],
             [[81,
               60],
              "assets/images/resized/0026/6126/266126v1-max-250x250.png"],
             [[81,
               60],
              "assets/images/resized/0026/6126/266126v1-max-450x450.png"]],
           "attribution": null}},
       "person": null},
      {"company": null,
       "financial_org":
        {"name": "Novartis Venture Fund",
         "permalink": "novartis-venture-fund",
         "image":
          {"available_sizes":
            [[[150,
               70],
              "assets/images/resized/0005/9083/59083v2-max-150x150.png"],
             [[250,
               117],
              "assets/images/resized/0005/9083/59083v2-max-250x250.png"],
             [[318,
               150],
              "assets/images/resized/0005/9083/59083v2-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "Headquarters",
    "address1": "260 Littlefield Avenue",
    "address2": "",
    "zip_code": "94080",
    "city": "South San Francisco",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": 37.645401,
    "longitude": -122.394464}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        94],
       "assets/images/resized/0005/0377/50377v1-max-150x150.png"],
      [[250,
        157],
       "assets/images/resized/0005/0377/50377v1-max-250x250.png"],
      [[450,
        284],
       "assets/images/resized/0005/0377/50377v1-max-450x450.png"]],
    "attribution": null}],
 "external_links":
  []}